Release Date: 4/26/2004

Case Turns On What Constitutes Adequate Warning

By Correy E. Stephenson

In the latest Rezulin case to reach trial, a New York jury awarded $2 million to a woman who suffered side effects from the diabetes drug, but had no evidence of permanent liver damage.

With approximately 8,700 Rezulin lawsuits filed in state and federal courts across the country, the April trial was closely watched for indications of whether the mass tort is likely to be successful.